Australian Capital Territory Government Buys Back Asbestos-Ridden Homes Without Secured Loan
The Australian Capital Territory bought back 19 “Mr. Fluffy” asbestos-ridden homes before the ACT and Commonwealth $1 billion loan was signed.
Australian Capital Territory Government Buys Back Asbestos-Ridden Homes Without Secured Loan
The Australian Capital Territory bought back 19 “Mr. Fluffy” asbestos-ridden homes before the ACT and Commonwealth $1 billion loan was signed.
Community rallies behind Wells chef, mother fighting mesothelioma
Friends and family are rallying around Marcy Mayo, a Wells resident recently diagnosed with mesothelioma, a cancer that most commonly results from exposure to asbestos. The goal is to help Marcy and her husband, Bruce, cover the expenses involved with …
Upcoming Mesothelioma Symposium Will Focus on Latest Research
Dr. Robert Cameron and other mesothelioma specialists are set to discuss latest treatment breakthroughs with health care professionals and the public.
Role of Hedgehog Signaling in Malignant Pleural Mesothelioma
Clinical Cancer Research , Vol. 18, No. 17. , pp. 4646-4656, doi:10.1158/1078-0432.ccr-12-0599 To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
Novartis solid tumor ‘Car T cell’ still holds promise: researcher
A new type of immuno-oncology treatment from Novartis AG proved safe in a tiny study of three types of solid tumors, but the trial included too few patients and used too small a dose of the experimental product to prove effectiveness, according to data…
AACR – Solid Tumour CAR-T Foray Lives Up To Its Low-Key Billing
For some time now solid tumours has been seen as the next big battleground for CAR-T therapy, but based on the underwhelming early data released yesterday at the AACR meeting the best that can be said is that the jury is still out. A very early trial o…
Article Image
One of Devon’s largest law firms is expanding its national-level expertise with the appointment of a consultant who comes from a top 100 London law firm. Terry Lee has joined Wollen Michelmore as a consultant solicitor in the civil dispute resolution d…
Traces of Asbestos Found During Nevada’s I-11 Route Construction
Naturally occurring asbestos was discovered near Las Vegas, Nevada during work on the new I-11 Interstate, which will be costly to remove.
Traces of Asbestos Found During Nevada’s I-11 Route Construction
Naturally occurring asbestos was discovered near Las Vegas, Nevada during work on the new I-11 Interstate, which will be costly to remove.
Investigational Personalized Cellular Therapy Tolerated Well by…
Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Perelman School of Medicine at the University of…
Investigational Personalized Cellular Therapy Tolerated Well by…
Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Perelman School of Medicine at the University of…
Investigational personalized cellular therapy tolerated well by patients with advanced mesothelioma, ovarian and pancreatic cancers
Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers. The data adds to a growing body of research showing the promise of CAR T cell technology.
Investigational personalized cellular therapy tolerated well by patients with advanced mesothelioma, ovarian and pancreatic cancers
Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers. The data adds to a growing body of research showing the promise of CAR T cell technology.
Immunotherapy drug pembrolizumab shows early promise for mesothelioma patients
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall,…